Newer biologic drugs and immunomodulatory agents, as well as more tolerated and
effective radiation therapy schemes, have reduced treatment toxicity in oncology patients …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide and one of the most common causes of death among patients with cirrhosis …

Background Intrahepatic cholangiocarcinoma (ICC) is the second most common type of
primary hepatic malignancy. Aim of this work is to analyse the features of ICC and its …

Simple Summary Magnetic Resonance Imaging (MRI) is a consolidated imaging tool for the
multiparametric assessment of tissues in various pathologies from degenerative and …

This article provides an overview of diagnostic evaluation and ablation treatment
assessment in Hepatocellular Carcinoma (HCC). Only studies, in the English language from …

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare type of primary liver
malignancy. Among the risk factors, hepatitis B and hepatitis C virus infections, cirrhosis, and …

Magnetic resonance imaging (MRI) is a non-invasive imaging technique (non-ionizing
radiation) with superior soft tissue contrasts and potential morphological and functional …

Simple Summary The present study aimed to investigate the possible use of MRI delta
texture analysis (D-TA) in order to predict the extent of pathological response in patients with …

The increase in oncology knowledge and the possibility of creating personalized medicine
by selecting a more suitable therapy related to tumor subtypes, as well as the patient's …

Dynamic contrast-enhanced (DCE) imaging is a non-invasive technique used for the
evaluation of tissue vascularity features through imaging series acquisition after contrast …